Long Noncoding RNA
LINC00551
PKM2
c-Myc
glycolysis
lung adenocarcinoma
Journal
OncoTargets and therapy
ISSN: 1178-6930
Titre abrégé: Onco Targets Ther
Pays: New Zealand
ID NLM: 101514322
Informations de publication
Date de publication:
2020
2020
Historique:
received:
19
08
2020
accepted:
07
10
2020
entrez:
18
11
2020
pubmed:
19
11
2020
medline:
19
11
2020
Statut:
epublish
Résumé
Lung adenocarcinoma (LUAD) is a leading cause of mortality associated with cancer globally. Thus, it is essential to elucidate its tumorigenesis and prognosis. Accumulating evidence shows that long noncoding RNAs (lncRNAs) play important roles in the occurrence and progression of tumors by regulating their glucose metabolism. Bioinformatics analysis was performed to explore the expression of Herein, we found that In summary, our study identifies
Sections du résumé
BACKGROUND
BACKGROUND
Lung adenocarcinoma (LUAD) is a leading cause of mortality associated with cancer globally. Thus, it is essential to elucidate its tumorigenesis and prognosis. Accumulating evidence shows that long noncoding RNAs (lncRNAs) play important roles in the occurrence and progression of tumors by regulating their glucose metabolism.
METHODS
METHODS
Bioinformatics analysis was performed to explore the expression of
RESULTS
RESULTS
Herein, we found that
CONCLUSION
CONCLUSIONS
In summary, our study identifies
Identifiants
pubmed: 33204101
doi: 10.2147/OTT.S273797
pii: 273797
pmc: PMC7665500
doi:
Types de publication
Journal Article
Langues
eng
Pagination
11459-11470Informations de copyright
© 2020 Wang et al.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest for this work.
Références
J Biol Chem. 2000 Jul 21;275(29):21797-800
pubmed: 10823814
Nat Cell Biol. 2016 Apr;18(4):431-42
pubmed: 26999735
J Cell Physiol. 2020 Jul 17;:
pubmed: 32677057
Cancers (Basel). 2020 Jan 03;12(1):
pubmed: 31947710
Nat Rev Cancer. 2014 Aug;14(8):535-46
pubmed: 25056707
Nature. 2010 Jan 21;463(7279):364-8
pubmed: 20010808
EMBO Rep. 2016 Aug;17(8):1204-20
pubmed: 27317567
Cell Death Dis. 2018 Aug 1;9(8):825
pubmed: 30068946
Biochem Biophys Res Commun. 2017 Aug 19;490(2):217-224
pubmed: 28602700
PLoS One. 2007 Sep 05;2(9):e845
pubmed: 17786216
Cell Mol Life Sci. 2019 Feb;76(3):495-504
pubmed: 30341461
Pharmacol Res. 2019 Dec;150:104511
pubmed: 31678210
Nat Commun. 2019 Aug 2;10(1):3499
pubmed: 31375671
Nat Commun. 2019 Mar 29;10(1):1405
pubmed: 30926812
J Pathol. 2020 Apr;250(5):480-495
pubmed: 32100288
Cancer Res. 2019 May 15;79(10):2480-2493
pubmed: 30914432
CA Cancer J Clin. 2016 Mar-Apr;66(2):115-32
pubmed: 26808342
Drug Discov Today. 2020 May;25(5):891-900
pubmed: 32105718
Trends Cell Biol. 2018 Apr;28(4):287-301
pubmed: 29274663
Mol Cancer. 2017 Sep 25;16(1):154
pubmed: 28946875
Cancer Lett. 2018 Apr 10;419:167-174
pubmed: 29366802
Lung Cancer. 2019 May;131:139-146
pubmed: 31027691
Front Oncol. 2019 Nov 26;9:1099
pubmed: 31850189
Mol Cancer. 2017 Jul 24;16(1):130
pubmed: 28738810
Lancet. 2017 Jan 21;389(10066):299-311
pubmed: 27574741
Sci Transl Med. 2011 Mar 23;3(75):75ra26
pubmed: 21430269
Sci Signal. 2010 Feb 02;3(107):ra8
pubmed: 20124551
Cancer Cell. 2016 Apr 11;29(4):548-562
pubmed: 27052953
Nat Rev Clin Oncol. 2014 Aug;11(8):473-81
pubmed: 24981256
Mol Cell Biol. 2007 Nov;27(21):7381-93
pubmed: 17785433
Proc Natl Acad Sci U S A. 2010 Feb 2;107(5):2037-42
pubmed: 20133848
Cell Cycle. 2016 Dec 16;15(24):3471-3481
pubmed: 27792451
J Clin Invest. 2016 Aug 1;126(8):2775-82
pubmed: 27479746
Oncogene. 2020 Mar;39(11):2408-2423
pubmed: 31959898